Hostname: page-component-77c78cf97d-v4t4b Total loading time: 0 Render date: 2026-05-04T18:53:49.254Z Has data issue: false hasContentIssue false

Oat agriculture, cultivation and breeding targets: implications for human nutrition and health

Published online by Cambridge University Press:  30 September 2014

Derek Stewart*
Affiliation:
Environmental and Biochemical Sciences Group, The James Hutton Institute, Dundee DD2 5DA, Scotland, UK BioForsk Nord-Holt, Postbox 2284, Trømso, Norway
Gordon McDougall
Affiliation:
Environmental and Biochemical Sciences Group, The James Hutton Institute, Dundee DD2 5DA, Scotland, UK
*
* Corresponding author: D. Stewart, fax +44 844 928 5429, email derek.stewart@hutton.ac.uk
Rights & Permissions [Opens in a new window]

Abstract

Oats are undervalued in comparison with wheat, rice and barley, despite their unique composition that includes many of the nutrients required for health and a reduced risk of degenerative disease incidence. Furthermore, oats as whole grain and some of their associated products also contain β-glucan, a complex polysaccharide that has an approved health claim to reduce blood cholesterol levels and reduce the risk of CHD incidence if consumed at ≥ 3 g/d. At the agronomic level, oats exhibit optimal growth in regions of moderate temperature and long day length. In addition, they can tolerate wet weather and acidic soils more effectively than other cereals, such as wheat. Studies have shown that there is diversity in the content and composition of nutrients and health-beneficial components within the available wild and cultivated germplasm and that these are amenable to be enhanced by different agronomic practices as well as are susceptible to climatic variation. The advances in modern plant genetics, developed in sister cereals such as wheat, rice and barley, mean that oat development and exploitation should see an acceleration in the coming decade as they are adopted and applied. These advances include approaches such as genome sequencing, genotyping by sequencing and the allied next-level analytical approaches of RNA sequencing, transcriptome profiling and metabolomics. The collation and coordination of these approaches should lead to the generation of new, tailored oat varieties that are nutritionally enhanced and contain a greater proportion of health-beneficial components that can be translated through into a wide(r) range of consumer products with the ultimate hope of associated benefits to human health and nutrition.

Information

Type
Full Papers
Copyright
Copyright © The Authors 2014 
Figure 0

Table 1 Nutritional composition of oatmeal and wholemeal wheat flour*†

Figure 1

Fig. 1 Global production levels of the main cereal crops (values are for the 2010 production figures)(10).

Figure 2

Fig. 2 Global production of oats from 1961 to 2010(10).

Figure 3

Fig. 3 Regionalised oat production for the years 1961 (■) and 2010 ()(10).

Figure 4

Fig. 4 Top twenty countries for oat production in 2010(10).

Figure 5

Table 2 Influence of environment factors on beneficial oat components

Figure 6

Fig. 5 A schematic description of the UK process of oat variety generation with approximations of the scale of effort involved. The parental cross schematic highlights the scale of plant lines needed to progress from the initial parental cross through generation to be multiplied up for assessment and ultimately for recommendation (RL) to farmers. NL (National Listing): this is a legal requirement for new varieties of the main agricultural and vegetable species that seeks to ensure that no new variety is marketed unless it is genuinely new and, for agricultural crops, an improvement in key characteristics on varieties already being sold. RL (Recommended Listing): this provides information on yield and quality performance, agronomic features and market options for recommended varieties to assist growers with variety selection. Varieties are generally trialled on an annual basis while they remain on the Recommended List. For oats in the UK, this is administered by the Home Grown Cereal Authority. RLT, Recommended Listing trials.